HUTCHMED (China) Limited
HUTCHMED (China) Limited (HMDCF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HMDCF · as of Jun 8, 2026
Key Statistics
Explore HUTCHMED (China) Limited Data
hmdcf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 66.7%
Competitors & Peers
hmdcf competitorsHMDCF
APNHF
APNHY
CHSYF
CURLF
DMPHFStock Performance
Full HistoryAbout HUTCHMED (China) Limited
HUTCHMED (China) Limited HUTCHMED (China) Ltd. operates as a holding company, specializing in the research, development, manufacturing, and sales of both pharmaceutical products and health-focused consumer goods. The company'…
what is hutchmed (china) limited · hmdcf stock overview · hutchmed (china) limited company profile · who is hutchmed (china) limited ceo · hmdcf OTC · hutchmed (china) limited headquarters · hutchmed (china) limited business segments
About Stock Overview & Key Data
HUTCHMED (China) Limited (HMDCF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Apr 17, 2014. As of the latest trading session, HMDCF stock price is $2.90, with a market capitalization of $2.5B. The stock has returned -9.38% over the past 12 months and -20.77% year-to-date.
According to 3 Wall Street analysts, the consensus rating for HUTCHMED (China) Limited stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, HUTCHMED (China) Limited reported revenue of $549.3M and net income of $457.6M. For detailed data — including HUTCHMED (China) Limited revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, HUTCHMED (China) Limited (HMDCF) stock price is $2.90. The stock is traded on OTC under the ticker symbol HMDCF. The 52-week range is $2.16 – $3.81.